P&G Scientists And Other Researchers Complete Genomic Study Of Skin-Disease-Causing Microbe

Scientists from Procter & Gamble joined an international team of researchers from A*STAR’s Genome Institute of Singapore, Institute of Medical Biology, and Bioinformatics Institute in completing the first genomic and biologic study of all species of Malassezia, a leading skin-disease-causing microbe. Results of the breakthrough study revealed many potential targets for treating diseases, including seborrheic dermatitis, eczema, and dandruff. Malassezia is also linked to skin cancer, the 6th most common cancer among men and 7th among females in Singapore. Also, the group’s findings improve scientists’ understanding of the human skin microbiome, with possible applications in dermatology and immunology.